Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Genomic and Clinical Features Associated with Reduced Susceptibility to Cefiderocol and Cross-resistance to β-lactam/β-lactamase Inhibitors in a Global Cohort of Pseudomonas aeruginosa.
Journal: The Journal of infectious diseases
Published: February 27, 2026
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Journal: Antimicrobial agents and chemotherapy
Published: July 12, 2024
Leishmaniasis masquerading as pyoderma gangrenosum in a non-endemic area: A case report.
Journal: The Australasian journal of dermatology
Published: May 26, 2024
Cefiderocol heteroresistance associated with mutations in TonB-dependent receptor genes in Pseudomonas aeruginosa of clinical origin.
Journal: bioRxiv : the preprint server for biology
Published: February 14, 2024
Clinical Features and Genomic Epidemiology of Bloodstream Infections due to Enterococcal Species Other Than Enterococcus faecalis or E. faecium in Patients With Cancer.
Journal: Open forum infectious diseases
Published: February 02, 2024
The emergence of cefiderocol resistance in Pseudomonas aeruginosa from a heteroresistant isolate during prolonged therapy.
Journal: Antimicrobial agents and chemotherapy
Published: December 08, 2023
Membrane Lipids Augment Cell Envelope Stress Signaling via the MadRS System to Defend Against Antimicrobial Peptides and Antibiotics in Enterococcus faecalis.
Journal: The Journal of infectious diseases
Published: November 03, 2023
Membrane Lipids Augment Cell Envelope Stress Signaling and Resistance to Antibiotics and Antimicrobial Peptides in Enterococcus faecalis.
Journal: bioRxiv : the preprint server for biology
Published: October 31, 2023
Co-Occurrence of Gram-Negative Rods in Patients with Hematologic Malignancy and Sinopulmonary Mucormycosis.
Journal: Journal of fungi (Basel, Switzerland)
Published: September 27, 2023
Case Commentary: Successful Use of Cefepime/Zidebactam (WCK 5222) as a Salvage Therapy for the Treatment of Disseminated Extensively Drug-Resistant New Delhi Metallo-β-Lactamase-Producing Pseudomonas aeruginosa Infection in an Adult Patient with Acute T-Cell Leukemia.
Journal: Antimicrobial agents and chemotherapy
Published: July 03, 2023
High-level ceftazidime/avibactam resistance in Escherichia coli conferred by the novel plasmid-mediated β-lactamase CMY-185 variant.
Journal: The Journal of antimicrobial chemotherapy
Published: February 07, 2023
Last Updated: 09/26/2026